DUBLIN--(BUSINESS WIRE)--The "Sleep Apnea Devices Market Size, Share & Trends Analysis Report By Product [Therapeutic (PAP, Oral, Nasal, Chin), Diagnostic (Respiratory Polygraphs, Actigraph, Polysomnography, Pulse Oximeters)], By Region, 2019 - 2025" report has been added to ResearchAndMarkets.com's offering.
The global sleep apnea devices market size is estimated to be worth USD 12.61 billion by 2025, expanding at a CAGR of 6.8% from 2019 to 2025.
Increasing number of patients suffering from sleep apnea, growing awareness, and treatment rate of these diseases in North America are some of the factors contributing to the revenue growth.
On the basis of product type, the market is categorized into therapeutic and diagnostic devices. Therapeutic device led the market with about 65.06% of revenue share in 2018, due to increased awareness and patient medication adherence in developed markets such as U.S. and Canada and high prevalence of Obstructive Sleep Apnea (OSA). PAP Devices led the therapeutic segment due to higher product adoption and availability and comparative higher patient outcome. The segment is expected to witness a CAGR of 5.1% between 2019 and 2025.
Diagnostic device segment comprises of actigraphs, polysomnography, respiratory polygraphs, and pulse oximeters. Polysomnography devices led the market with 34.88% of revenue share in 2018 and is estimated to witness a CAGR of 7.05% over the forecast period. As there is no gold standard for diagnosis of OSA, polysomnography is one of the most preferred diagnostic tests for sleep apnea. Increase in preference of polysomnography test is expected to drive the market revenue between 2019 and 2025.
Sleep apnea PAP devices have witnessed significant development in terms of design, safety, and efficacy has helped to boost product adoption and patient outcome. Moreover, miniaturization of PAP devices and availability of cheaper brands is expected to fuel growth of the sleep apnea devices market over the forecast period.
Some of the key manufacturers are BMC Medical Co. Ltd., GE Healthcare, Fisher & Paykel Healthcare Limited, Curative Medical Inc., Cadwell Laboratories ResMed, Invacare Corporation, Braebon Medical Corporation, ImThera Medical Inc., Phillips Respironics, Curative Medical Inc., Nihon Kohden, and Compumedics Limited.
Further key findings from the report suggest:
- Therapeutic devices segment led the market in 2018, with a revenue of USD 5,302.1 million, due to high prevalence of OSA, increased treatment rate, patient adherence, and availability of technologically advanced products.
- Oral devices segment is anticipated to exhibit the fastest CAGR of 11.7% over the forecast period as these products offer higher patient outcome, lower economic burden, and higher treatment adherence due to their smaller size.
- Some of the key players operating in the sleep apnea devices market are BMC Medical Co. Ltd., GE Healthcare, Fisher & Paykel Healthcare Limited, Curative Medical Inc., Cadwell Laboratories, ResMed, Invacare Corporation, Braebon Medical Corporation, ImThera Medical Inc., Phillips Respironics, Curative Medical Inc., Nihon Kohden, and Compumedics Limited.
Key Topics Covered
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
2.1 Sleep Apnea Devices Market Outlook, By Revenue (USD Million)
2.2 Sleep Apnea Devices Market Segment Outlook, By Revenue (USD Million)
2.3 Competitive Insights
Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Sleep Apnea Devices Market Dynamics
3.2.1 Market Driver Analysis
22.214.171.124 Increasing prevalence of obstructive sleep apnea in chronic obstructive pulmonary disease (COPD)
126.96.36.199 Increasing prevalence of obesity and diabetes associated with sleep apnea
3.2.2 Market Restraint Analysis
188.8.131.52 High cost of diagnosis and treatment of sleep apnea
3.2.3 Penetration & Growth Prospect Mapping
3.2.4 Industry Analysis - Porter's
184.108.40.206 Supplier Power
220.127.116.11 Buyer Power
18.104.22.168 Substitution Threat
22.214.171.124 Threat from new entrant
126.96.36.199 Competitive Rivalry
3.2.5 PESTEL Analysis
188.8.131.52 Political Landscape
184.108.40.206 Environmental Landscape
220.127.116.11 Social Landscape
18.104.22.168 Technology Landscape
22.214.171.124 Legal Landscape
3.2.6 Sleep Apnea Patient Pool
3.2.7 Sleep Apnea Devices: Product Adoption Analysis
3.2.8 Sleep Apnea Devices: Supply Chain Analysis
3.2.9 Case Studies (Business Model /Technology Adoption)
Chapter 4 Sleep Apnea Devices Market Estimates & Trend Analysis, by product type
4.1 Sleep Apnea Devices Market Snapshot (Market Size, CAGR, Top Verticals, Key Players, Top Trends)
4.2 Product Market Share Analysis, 2018
4.3 Therapeutic Devices
4.3 2 Oral Devices
4.4 Diagnostic Devices
Chapter 5 Sleep apnea devices Market: Regional Estimates & Trend Analysis, by Product
5.1 Regional Market Snapshot
5.2 Regional Market Share and Leading Players, 2018
5.3 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
5.4 Market Size, & Forecasts, and Trend Analysis, 2018 to 2025
Chapter 6 Competitive Landscape
6.1 Company Profiles
6.2. Braebon Medical Corporation
6.3. Carefusion Corp
6.4. Compumedics Limited
6.5. Curative Medical Inc.
6.6. Fisher & Paykel Healthcare
6.7. GE Healthcare
6.8. ImThera Medical Inc.
6.9. Invacare Corporation
6.10. Itamar Medical Ltd.
6.11. Natus Medical Inc.
6.12. Nihon Kohden
6.13. Philips Respironics
6.14. ResMed Inc.
6.15. Somnetics International Inc.
6.16. SOMNOmedics GmbH
6.17. Teleflex Inc.
6.18. Weinmann Medical Devices GmbH & Co. KG
For more information about this report visit https://www.researchandmarkets.com/r/caqnlk